Cambridge Trust’s Axalta AXTA Stock Holding History

Cambridge Trust’s Portfolio AXTA Stock Details AXTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-204	Closed	-$7K	–	937
2021 Q4	$7K	Buy	+204	New	+$6.47K	﹤0.01%	860

Other funds holding AXTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return

Cambridge Trust's AXTA Position: Q1 2022 in Review

Cambridge Trust sold out of Axalta (AXTA) in Q1 2022, closing a stake of 204 shares — an estimated $7K sold.

Cambridge Trust first reported a position in AXTA in Q4 2021 and held it in 1 quarter. The position peaked at $7K in Q4 2021. 303 funds tracked by Wall St. Rank hold AXTA as of Q1 2022.

Cambridge Trust reported no remaining Axalta position as of Q1 2022 after selling out during the quarter.
Cambridge Trust sold 204 Axalta shares in Q1 2022, an estimated $7K.
Cambridge Trust first reported a position in Axalta in Q4 2021 and held it in 1 quarter.
Cambridge Trust's Axalta position peaked at $7K in Q4 2021.
303 funds tracked by Wall St. Rank held Axalta as of Q1 2022.

Based on Cambridge Trust's 13F filing for Q1 2022, filed 12 May 2022.